###begin article-title 0
Myd88 Is Required for an Antibody Response to Retroviral Infection
###end article-title 0
###begin p 1
Conceived and designed the experiments: EPB. Performed the experiments: EPB. Analyzed the data: EPB DRL. Wrote the paper: EPB DRL.
###end p 1
###begin p 2
###xml 478 479 478 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 965 966 965 966 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 1115 1116 1115 1116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1358 1359 1358 1359 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 427 430 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 619 624 <span type="species:ncbi:10090">mouse</span>
###xml 646 674 <span type="species:ncbi:11795">Friend murine leukemia virus</span>
###xml 900 904 <span type="species:ncbi:10090">mice</span>
###xml 1045 1049 <span type="species:ncbi:10090">mice</span>
###xml 1069 1073 <span type="species:ncbi:10090">mice</span>
###xml 1258 1262 <span type="species:ncbi:10090">mice</span>
###xml 1281 1285 <span type="species:ncbi:10090">mice</span>
Although retroviruses have been extensively studied for many years, basic questions about how retroviral infections are detected by the immune system and which innate pathways are required for the generation of immune responses remain unanswered. Defining these pathways and how they contribute to the anti-retroviral immune responses would assist in the development of more effective vaccines for retroviral pathogens such as HIV. We have investigated the roles played by CD11c+ dendritic cells (DCs) and by Toll-like receptor (TLR) signaling pathways in the generation of an anti-retroviral immune response against a mouse retroviral pathogen, Friend murine leukemia virus (F-MLV). Specific deletion of DCs during F-MLV infection caused a significant increase in viral titers at 14 days post-infection, indicating the importance of DCs in immune control of the infection. Similarly, Myd88 knockout mice failed to control F-MLV, and sustained high viral titers (107 foci/spleen) for several months after infection. Strikingly, both DC-depleted mice and Myd88 knockout mice exhibited only a partial reduction of CD8+ T cell responses, while the IgG antibody response to F-MLV was completely lost. Furthermore, passive transfer of immune serum from wild-type mice to Myd88 knockout mice rescued control of F-MLV. These results identify TLR signaling and CD11c+ DCs as playing critical roles in the humoral response to retroviruses.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 51 54 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 185 188 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 369 374 <span type="species:ncbi:10090">mouse</span>
###xml 907 910 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Efforts to develop vaccines against the retrovirus HIV by inducing immune responses involving antibodies or T cells have been unsuccessful. Although antibodies can be generated against HIV, they fail to neutralize the virus. Thus, a more fundamental understanding of how neutralizing antibody responses to retroviral pathogens are generated is required. We have used a mouse retrovirus to demonstrate that Myd88, a molecule centrally involved in innate immune system signaling, is required to generate an antibody response during retroviral infection. Myd88 also contributed to, but was not strictly required for, the T cell response. Myd88 is known to participate in a signaling pathway that activates inflammation in response to microbial molecules. Understanding how this pathway contributes to anti-retroviral antibody responses may be useful for the development of a vaccine that can effectively block HIV.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 279 282 279 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Kwong1">[1]</xref>
###xml 283 286 283 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Wyatt1">[2]</xref>
###xml 317 318 317 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 483 486 483 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Day1">[3]</xref>
###xml 487 490 487 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Trautmann1">[4]</xref>
###xml 703 706 703 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Pantaleo1">[5]</xref>
###xml 1047 1054 1047 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 4 7 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 100 103 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 132 135 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 301 304 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The HIV pandemic has spurred intensive research into retroviruses, and yet an effective vaccine for HIV has remained elusive. Acute HIV infection stimulates both B and T cell responses, but the antibody response is ineffective, possibly due to shielding of neutralizing epitopes [1],[2]. By contrast, HIV-specific CD8+ T cells are able to control infection early on, but become progressively less effective during the chronic phase of infection due to mechanisms that remain unclear [3],[4]. Vaccines designed to stimulate protective B cell or T cell responses have been used in clinical trials, but have been unsuccessful at either preventing infection or reducing viral titers in infected individuals [5]. Thus, a more fundamental understanding of anti-retroviral immune responses is needed to develop an effective vaccine. Basic questions that have not been answered include: 1) Which antigen presenting cell populations are necessary or sufficient to generate an immune response? 2) Which innate signaling pathways detect retroviral infection in vivo and are responsible for initiating adaptive immune responses?
###end p 6
###begin p 7
###xml 427 430 427 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Medzhitov1">[6]</xref>
###xml 783 786 783 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Kopp1">[7]</xref>
###xml 937 940 937 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Heil1">[8]</xref>
###xml 941 944 941 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Diebold1">[9]</xref>
###xml 972 976 972 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Sarkar1">[10]</xref>
###xml 1014 1018 1014 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Hemmi1">[11]</xref>
###xml 1102 1106 1102 1106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Medzhitov2">[12]</xref>
###xml 1385 1389 1381 1385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Barton1">[13]</xref>
###xml 1479 1483 1475 1479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Yamamoto1">[14]</xref>
###xml 601 607 <span type="species:ncbi:9606">Humans</span>
###xml 639 643 <span type="species:ncbi:10090">mice</span>
There have been major advances during the past decade in our understanding of how the innate immune system functions to limit viral growth and stimulate T and B cell- dependent adaptive immune responses. It is now understood that microbial products that serve as pathogen-associated molecular patterns (PAMPs) are detected by germline-encoded innate immune receptors, such as the members of the Toll-like receptor (TLR) family [6]. These receptors are prominently expressed in antigen-presenting cells such as dendritic cells (DCs) that function at the interface between innate and adaptive immunity. Humans encode at least ten TLRs while mice encode at least twelve. Products of bacterial metabolic pathways are recognized by specific TLRs such as LPS by TLR4 and flagellin by TLR5 [7]. Viruses, by contrast, are thought to be detected by mechanisms that involve endosomal localization of viral nucleic acids. ssRNA is detected by TLR7 [8],[9], dsRNA is detected by TLR3 [10], and CpG dsDNA is recognized by TLR9 [11]. All TLRs except for TLR3 signal through a pathway that involves the adaptor Myd88 [12]. Upon stimulation, Myd88 is recruited to the TLR as a dimer, and activates the kinases IRAK1 and IRAK4. This activates a signaling cascade that ultimately leads to the activation of the pro-inflammatory transcription factor NF-kappaB, as well as the MAP kinase and JNK pathways [13]. In the absence of Myd88, TLR3 and TLR4 are able to signal through another adaptor, TRIF [14].
###end p 7
###begin p 8
###xml 189 193 189 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Hasenkrug1">[15]</xref>
###xml 721 722 721 722 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 849 853 849 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Dittmer1">[16]</xref>
###xml 0 28 <span type="species:ncbi:11795">Friend murine leukemia virus</span>
###xml 275 301 <span type="species:ncbi:11819">spleen focus-forming virus</span>
###xml 303 307 <span type="species:ncbi:11819?1.0">SFFV</span>
###xml 310 314 <span type="species:ncbi:11819?1.0">SFFV</span>
###xml 478 482 <span type="species:ncbi:10090">mice</span>
###xml 534 539 <span type="species:ncbi:10090">mouse</span>
###xml 679 683 <span type="species:ncbi:10090">mice</span>
Friend murine leukemia virus (F-MLV) is a complex gamma-retrovirus that has been used to understand basic principles of anti-retroviral immune responses and mechanisms of chronic infection [15]. It consists of a replication-competent helper virus and a replication-defective spleen focus-forming virus (SFFV). SFFV encodes a protein, gp55, which binds to the erythropoietin receptor and causes hyper-proliferation of erythroid precursors and splenomegaly. The susceptibility of mice to F-MLV is affected by a number of host genes. In mouse strains such as Balb/c, immune responses are ineffective and sustained high virus titers eventually lead to erythroid leukemia. In C57BL/6 mice, acute infection is controlled by CD8+ T cells and neutralizing antibodies, but the virus is not completely cleared and establishes a low level persistent infection [16].
###end p 8
###begin p 9
###xml 121 125 121 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Meier1">[17]</xref>
###xml 278 282 278 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Beignon1">[18]</xref>
###xml 366 373 366 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 25 28 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 239 242 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Retroviral particles for HIV and F-MLV possess potential TLR ligands, and could conceivably be detected by TLR signaling [17]. Indeed, some evidence has indicated that plasmacytoid dendritic cells secrete type I interferons in response to HIV by way of a TLR7-dependent pathway [18]. However, the role played by TLRs in generating an anti-retroviral immune response in vivo is unknown.
###end p 9
###begin p 10
###xml 53 54 53 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 131 138 131 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 189 190 189 190 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 146 150 <span type="species:ncbi:10090">mice</span>
###xml 222 226 <span type="species:ncbi:10090">mice</span>
In this study, we addressed the roles played by CDllc+ DCs and Myd88-dependent signaling in the immune response to F-MLV infection in vivo. Using mice that permit specific deletion of CD11c+ DCs as well as Myd88-deficient mice, we determined that DCs and Myd88 contribute to, but are not required for, T cell responses to F-MLV, but are absolutely required for the generation of virus-neutralizing antibodies.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
###xml 27 34 27 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
F-MLV replication kinetics in vivo
###end title 12
###begin p 13
###xml 368 372 368 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Robertson1">[19]</xref>
###xml 412 419 412 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 623 624 623 624 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 702 703 702 703 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 710 711 710 711 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 729 737 729 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000298-g001">Figure 1</xref>
###xml 814 818 814 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Robertson1">[19]</xref>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 303 306 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 438 441 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
###xml 463 467 <span type="species:ncbi:10090">mice</span>
###xml 799 802 <span type="species:ncbi:11048?0.5860927152317881">LDV</span>
Previous reports demonstrated that F-MLV titers in the spleens of infected mice peak at 14 days post-infection (dpi) before they subside to a low level during the phase of chronic infection. However, F-MLV stocks used in the earlier studies were contaminated with Lactate Dehydrogenase-Elevating Virus (LDV), which has been shown to delay the immune response to F-MLV [19]. To establish growth kinetics of F-MLV in vivo in the absence of LDV, we infected C57BL/6 mice with F-MLV and measured viral titers in the spleen at different times post-infection. The number of foci per spleen peaked around 7 dpi at approximately 106 foci per spleen, and by 14 dpi the viral titer had been reduced to between 102 and 103 foci per spleen (Figure 1). This growth curve is consistent with a recent report using LDV-free F-MLV [19].
###end p 13
###begin title 14
###xml 19 26 19 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
F-MLV growth curve in vivo.
###end title 14
###begin p 15
###xml 140 149 140 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mus Dunni</italic>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
C57BL/6 mice were infected with F-MLV. At the time indicated, the number of viral foci in the spleen was measured by focus-forming assay on Mus Dunni cells. Each bar represents the average of five mice. The data shown are representative of two independent experiments.
###end p 15
###begin title 16
###xml 49 56 49 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
F-MLV infection causes dendritic cell maturation in vivo
###end title 16
###begin p 17
###xml 381 382 381 382 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 391 392 387 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 397 398 393 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 496 497 492 493 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 512 515 508 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int</sup>
###xml 520 521 516 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 530 531 522 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 596 600 588 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Siegal1">[20]</xref>
###xml 607 608 599 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 613 614 605 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 623 624 611 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 704 705 692 693 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 714 718 702 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Burgdorf1">[21]</xref>
###xml 1179 1187 1167 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000298-g002">Figure 2</xref>
###xml 1339 1346 1327 1334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 299 304 <span type="species:ncbi:10090">Mouse</span>
###xml 976 980 <span type="species:ncbi:10090">mice</span>
Dendritic cells (DCs) are specialized cells that carry out a number of important roles. They detect pathogens through innate receptors and activate signaling pathways that lead to the expression of cytokines. Furthermore, they present foreign antigens to T cells by way of MHCI and MHCII molecules. Mouse splenic DCs consist of three major subsets with specialized functions. CDllc+ CD8alpha- B220- ("myeloid") DCs are the classical antigen-presenting cell and are important for activation of CD4+ T cells. CDllcInt B220+ CD8alpha- ("plasmacytoid") DCs are potent producers of type 1 interferons [20]. CDllc+ B220- CD8alpha+ DCs are specialized for cross presentation and are important for activating CD8+ T cells [21]. When DCs detect foreign pathogens they mature and up-regulate their antigen presenting machinery as well as costimulatory molecules such as CD80 and CD86. To determine if F-MLV causes activation of specific DC subsets during infection, we infected C57BL/6 mice with F-MLV and examined the expression of CD80 and CD86 on all three splenic DC subsets at different times post-infection. CD80 and CD86 were upregulated on all three DC subsets beginning at 7 dpi (Figure 2). DC expression of CD80 and CD86 levels returned to baseline by 14 dpi. This indicates that all three DC subsets mature in response to F-MLV infection in vivo, and that DC activation peaks between 7-10 dpi.
###end p 17
###begin title 18
F-MLV infection causes dendritic cell maturation in vivo.
###end title 18
###begin p 19
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 205 209 <span type="species:ncbi:10090">mice</span>
###xml 232 236 <span type="species:ncbi:10090">mice</span>
###xml 270 274 <span type="species:ncbi:10090">mice</span>
C57BL/6 mice were infected with F-MLV. At the times indicated, dendritic cell populations in the spleen were analyzed for maturation by staining for CD80 and CD86. Each FACS plot is representative of five mice. Data from uninfected mice are shown in red, while infected mice are shown in blue. The data shown are representative of three independent experiments.
###end p 19
###begin title 20
DCs are required for control of F-MLV replication
###end title 20
###begin p 21
###xml 41 42 41 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 108 112 108 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Miyazawa1">[22]</xref>
###xml 389 390 389 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 544 548 544 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Jung1">[23]</xref>
###xml 712 719 712 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 439 454 <span type="species:ncbi:10090">transgenic mice</span>
###xml 582 588 <span type="species:ncbi:10090">murine</span>
###xml 796 800 <span type="species:ncbi:10090">mice</span>
###xml 921 925 <span type="species:ncbi:10090">mice</span>
###xml 1002 1006 <span type="species:ncbi:10090">Mice</span>
Immune control of F-MLV requires both CD8+ cytotoxic T lymphocyte (CTL) and neutralizing antibody responses [22]. Several cell types, including DCs, macrophages and B cells, are capable of antigen presentation to T cells, but for most pathogens it is unclear which of these cell types is explicitly required for the generation of specific immune responses. To investigate the role of CD11c+ DCs in immune function, we previously developed transgenic mice that express the diphtheria toxin receptor (DTR) under the control of the CD11c promoter [23]. Since expression of DTR renders murine cells susceptible to killing by diphtheria toxin (DT), this transgene allows for specific deletion of CDllc-expressing DCs in vivo by the administration of DT. Because repeated administration of DT to these mice is lethal within 7 days due to an unknown mechanism, we generated bone marrow chimeras, by lethally irradiating C57BL/6 mice and reconstituting them with wild-type or CDllc-DTR transgenic bone marrow. Mice receiving the transgenic bone marrow are viable through at least 2 weeks of repeated DT injection.
###end p 21
###begin p 22
###xml 39 40 39 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 349 350 349 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 383 392 383 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000298-g003">Figure 3A</xref>
###xml 519 540 519 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000298-g003">Figure 3B, left panel</xref>
###xml 568 569 568 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 797 819 797 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000298-g003">Figure 3B, right panel</xref>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
###xml 231 235 <span type="species:ncbi:10090">mice</span>
###xml 467 471 <span type="species:ncbi:10090">mice</span>
###xml 513 517 <span type="species:ncbi:10090">mice</span>
###xml 753 757 <span type="species:ncbi:10090">mice</span>
To investigate the role played by CD11c+ DCs in the immune response to a retrovirus, we infected the chimeric mice with F-MLV. To delete DCs, we injected 200 ng DT daily from one day prior to infection until 14 dpi. At 14 dpi, the mice were sacrificed, and the extent of DC depletion in the spleen was determined by flow cytometry. Deletion of CD11c+ cells was typically around 90% (Figure 3A). Strikingly, the number of infectious foci in the spleens of DC-depleted mice was 100-fold higher than in non-depleted mice (Figure 3B, left panel). This indicates that CDllc+ DCs play an essential role in immune control of F-MLV, and that other antigen presenting cells are not sufficient for full activation of anti-retroviral immune responses. DC-depleted mice also exhibited increased splenomegaly (Figure 3B, right panel), indicative of higher levels of virus.
###end p 22
###begin title 23
Dendritic cells are required for immune control of F-MLV infection.
###end title 23
###begin p 24
###xml 28 32 <span type="species:ncbi:10090">mice</span>
###xml 214 218 <span type="species:ncbi:10090">mice</span>
###xml 492 496 <span type="species:ncbi:10090">mice</span>
Lethally irradiated C57BL/6 mice that had been reconstituted with wild-type (WT) or CD11c-DTR bone marrow were infected intravenously with F-MLV. DT was injected intraperitoneally into both wild-type and CD11c-DTR mice every day from one day prior to infection until 14 days post-infection. At 14 days post-infection, spleens were harvested, the level of DC depletion analyzed (A), and the number of viral foci per spleen and spleen weight were measured (B). Each bar is the average of seven mice for each group. The data shown are representative of three independent experiments.
###end p 24
###begin p 25
###xml 235 243 235 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000298-g002">Figure 2</xref>
###xml 394 398 <span type="species:ncbi:10090">mice</span>
To learn about the temporal requirement for DCs in immune control of F-MLV infection, we also depleted DCs from day 4 to 14 following infection. We had previously observed strong activation of DC populations in the spleen at 7-10 dpi (Figure 2). Interestingly, depletion from day 4-14 post-infection did not result in a significant increase in virus titers in the spleen relative to undepleted mice (not shown). This suggests that the presence of DCs during the first four days of infection is sufficient to establish immune control, and that the mature DC populations visible later in infection are not required.
###end p 25
###begin title 26
DCs are required for the neutralizing antibody response to F-MLV
###end title 26
###begin p 27
###xml 206 207 206 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 465 466 465 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 525 526 525 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 591 592 591 592 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 617 621 617 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Dittmer1">[16]</xref>
###xml 658 659 658 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 687 688 687 688 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 777 778 777 778 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 846 855 846 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000298-g004">Figure 4A</xref>
###xml 939 940 939 940 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1009 1010 1009 1010 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 562 567 <span type="species:ncbi:10090">mouse</span>
###xml 612 616 <span type="species:ncbi:10090">mice</span>
###xml 735 739 <span type="species:ncbi:10090">mice</span>
Since DC-depleted mice exhibited reduced ability to control F-MLV, we wished to determine whether either the CTL or neutralizing antibody response was affected by the depletion. To measure the role of CD11c+ DCs in the CTL response, we infected chimeras reconstituted with wild-type or CDllc-DTR bone marrow with F-MLV. DCs were depleted by injection of DT from one day prior to infection until 14 days post-infection. At 14 dpi, splenocytes were stained with the Db-GagL tetramer. This tetramer typically stains 5-10% of CD8+ CTLs in a F-MLV-infected wild-type mouse, but does not stain CD8+ T cells from naive mice [16]. We found that the proportion of CD8+ T cells that stained with Db-GagL was only slightly reduced in DC-depleted mice, suggesting that high levels of CD11c+ DCs are not required for the generation of CTL responses to F-MLV (Figure 4A). It is possible that only a small number of DCs is sufficient for activating a CD8+ T cell responses, or that a non-depleted APC population mediates CD8+ T cell activation.
###end p 27
###begin title 28
Dendritic cells are required for the neutralizing antibody response to F-MLV.
###end title 28
###begin p 29
###xml 59 60 59 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 143 144 143 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 190 191 190 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 217 218 217 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 269 270 269 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 627 636 627 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mus Dunni</italic>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
###xml 406 410 <span type="species:ncbi:10090">mice</span>
###xml 458 462 <span type="species:ncbi:10090">mice</span>
###xml 678 683 <span type="species:ncbi:10090">mouse</span>
(A) In dendritic cell-depleted F-MLV-infected mice, the CD8+ T cell response to F-MLV at 14 dpi was measured by staining splenocytes with the Db-GagL tetramer. Representative FACS plots of DbGagL staining gated on CD8+ cells are shown on the left. The proportion of CD8+ T cells that stained with GagL was calculated for each sample and is shown on the right. Each bar represents the average value of four mice. (B) In dendritic cell-depleted F-MLV-infected mice, the titer of F-MLV-neutralizing antibodies in the serum was measured. Numerical values represent the maximum dilution of serum that neutralized F-MLV infection of Mus Dunni cells. Each dot represents an individual mouse. The data shown are representative of three independent experiments.
###end p 29
###begin p 30
###xml 474 483 474 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mus Dunni</italic>
###xml 689 698 689 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000298-g004">Figure 4B</xref>
###xml 737 738 737 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 263 267 <span type="species:ncbi:10090">mice</span>
###xml 531 535 <span type="species:ncbi:10090">mice</span>
###xml 624 628 <span type="species:ncbi:10090">mice</span>
To assess the role of DCs in the generation of neutralizing antibodies against F-MLV, we infected the bone marrow chimeras with F-MLV and depleted DCs by injection of DT from day -1 to day 14 post-infection. At 14 dpi, we harvested peripheral blood from infected mice and isolated serum. We then measured the titer of F-MLV-specific neutralizing antibodies in the serum by determining the maximum dilution of serum that was still sufficient to neutralize F-MLV infection of Mus Dunni cells in tissue culture. In wild-type infected mice, neutralizing antibody titers were typically between 40-160. Strikingly, in DC depleted mice, neutralizing antibodies were undetectable, with titers<10 (Figure 4B). These results demonstrate that CD11c+ DCs play an essential role in the generation of F-MLV-specific neutralizing antibodies, but are less important for CTL responses.
###end p 30
###begin title 31
Myd88 is required for immune control of F-MLV
###end title 31
###begin p 32
###xml 136 139 136 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 953 954 953 954 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 961 962 961 962 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1046 1047 1046 1047 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 1053 1054 1053 1054 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1173 1174 1173 1174 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1177 1178 1177 1178 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1240 1241 1240 1241 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1244 1245 1244 1245 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 1290 1299 1290 1299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000298-g005">Figure 5A</xref>
###xml 1594 1603 1594 1603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000298-g005">Figure 5B</xref>
###xml 1839 1848 1839 1848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000298-g005">Figure 5C</xref>
###xml 249 253 <span type="species:ncbi:10090">mice</span>
###xml 412 416 <span type="species:ncbi:10090">mice</span>
###xml 433 437 <span type="species:ncbi:10090">mice</span>
###xml 629 633 <span type="species:ncbi:10090">mice</span>
###xml 720 724 <span type="species:ncbi:10090">mice</span>
###xml 897 901 <span type="species:ncbi:10090">mice</span>
###xml 919 923 <span type="species:ncbi:10090">mice</span>
###xml 1006 1010 <span type="species:ncbi:10090">mice</span>
###xml 1119 1123 <span type="species:ncbi:10090">mice</span>
###xml 1217 1221 <span type="species:ncbi:10090">mice</span>
###xml 1492 1496 <span type="species:ncbi:10090">mice</span>
###xml 1547 1551 <span type="species:ncbi:10090">mice</span>
###xml 1636 1640 <span type="species:ncbi:10090">mice</span>
###xml 1715 1719 <span type="species:ncbi:10090">mice</span>
###xml 1770 1774 <span type="species:ncbi:10090">mice</span>
Because F-MLV particles contain molecules such as ssRNA that could activate TLR signaling, we reasoned that infection might be detected via a TLR-dependent pathway. To test whether TLR signaling was required for immune control of F-MLV, we infected mice heterozygous or homozygous for a null Myd88 allele and analyzed virus levels in the spleens at various time-points post-infection. We also compared wild-type mice to heterozygous mice at several time-points over an eight week period and found no significant difference in viral titers, so all comparisons in subsequent studies were between heterozygous and homozygous mutant mice. In the first 7 days after infection, viral levels were slightly higher in Myd88 null mice than in heterozygotes, but they reached a similar peak level at one week post-infection (wpi). At two wpi, however, viral titers were dramatically higher in Myd88 knockout mice. In heterozygous mice, titers dropped to between 102 and 103 foci per spleen, whereas in Myd88 knockout mice virus titers remained at between 105 and106 foci per spleen. Furthermore, at 8 wpi and 16 wpi, heterozygous mice had developed a low level chronic infection at 102-103 foci per spleen, while Myd88 knockout mice exhibited high (106-107 foci per spleen) levels of virus infection (Figure 5A). This suggested that some aspect of immune control of F-MLV is impaired in the absence of Myd88. In contrast with DC depletion, splenomegaly was not enhanced relative to that in heterozygous mice at 2 wpi. By 16 wpi, however, some Myd88 knockout mice exhibited significantly enlarged spleens (Figure 5B). Interestingly, Myd88 knockout mice did not show a significant increase in mortality relative to heterozygous mice over 16 weeks of infection, and infected knockout mice seemed otherwise healthy despite maintaining high virus titers (Figure 5C).
###end p 32
###begin title 33
Myd88 is required for immune control of F-MLV.
###end title 33
###begin p 34
###xml 15 19 <span type="species:ncbi:10090">mice</span>
###xml 178 182 <span type="species:ncbi:10090">mice</span>
###xml 282 286 <span type="species:ncbi:10090">mice</span>
###xml 323 327 <span type="species:ncbi:10090">mice</span>
Myd88 knockout mice and heterozygous littermates were infected with F-MLV. (A) At the times indicated, the viral titer in the spleen was measured. Each bar is the average of 4-8 mice. (B) At the times indicated, the weight of the spleen was measured. Each bar is the average of 4-8 mice. (C) The survival of Myd88 knockout mice and heterozygous littermates was measured over a 16-week period. The data shown are representative of two independent experiments.
###end p 34
###begin title 35
###xml 14 21 14 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
DC maturation in vivo partially requires Myd88
###end title 35
###begin p 36
###xml 331 339 331 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000298-g002">Figure 2</xref>
###xml 484 485 484 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 490 491 490 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 500 501 496 497 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 559 579 555 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000298-g006">Figure 6, left panel</xref>
###xml 587 588 583 584 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 593 594 589 590 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 603 604 595 596 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 618 621 610 613 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sup>
###xml 626 627 618 619 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 636 637 624 625 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 751 784 739 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000298-g006">Figure 6, middle and right panels</xref>
###xml 273 277 <span type="species:ncbi:10090">mice</span>
###xml 441 445 <span type="species:ncbi:10090">mice</span>
###xml 469 473 <span type="species:ncbi:10090">mice</span>
We had previously observed that the three major DC subsets in the spleen undergo maturation between 7 and 10 days post-infection. To determine if DC maturation was dependent on Myd88, we analyzed expression of CD80 at 7 dpi on splenic DCs of Myd88 heterozygous or knockout mice that had been infected with F-MLV. As shown earlier (Figure 2), F-MLV infection caused up-regulation of CD80 on all three major splenic DC subsets in heterozygous mice. In the Myd88 knockout mice, the CD11c+ B220- CD8alpha- DCs exhibited little reduction in up-regulation of CD80 (Figure 6, left panel). CD11c+ B220- CD8alpha+ DCs and CD11cint B220+ CD8alpha- DCs, by contrast, exhibited more pronounced reduction in maturation, but still exhibited some response to F-MLV (Figure 6, middle and right panels). This suggests that both Myd88-dependent and independent pathways contribute to the maturation of DCs in response to F-MLV, and that the contribution made by Myd88-dependent signaling varies somewhat between different DC subsets.
###end p 36
###begin title 37
Dendritic cell maturation during F-MLV infection is partially dependent on Myd88.
###end title 37
###begin p 38
###xml 178 179 178 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 184 185 184 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 194 195 190 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 202 203 198 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 218 219 210 211 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 230 233 222 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sup>
###xml 239 240 231 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 249 250 237 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 15 19 <span type="species:ncbi:10090">mice</span>
###xml 341 345 <span type="species:ncbi:10090">mice</span>
Myd88 knockout mice and heterozygous littermates were infected with F-MLV. At 7 dpi, splenic DCs were stained for expression of CD80. The populations were gated as follows: CD11c+ B220- CD8alpha-, CD11c+ B220- CD8alpha+, and CD11cint, B220+ CD8alpha+. A representative histogram of CD80 staining from three independent experiments using 4-6 mice is shown for each population.
###end p 38
###begin title 39
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 12 13 12 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
CD8+ and CD4+ T cell responses to F-MLV are present but reduced in the absence of Myd88
###end title 39
###begin p 40
###xml 129 130 129 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 143 144 143 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 165 169 165 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Hasenkrug2">[24]</xref>
###xml 389 390 389 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 406 415 406 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000298-g007">Figure 7A</xref>
###xml 469 470 469 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 526 547 526 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000298-g007">Figure 7A, left panel</xref>
###xml 662 663 662 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 682 683 682 683 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 688 689 688 689 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 737 759 737 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000298-g007">Figure 7A, right panel</xref>
###xml 789 790 789 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 256 260 <span type="species:ncbi:10090">mice</span>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
###xml 434 438 <span type="species:ncbi:10090">mice</span>
###xml 559 563 <span type="species:ncbi:10090">mice</span>
###xml 635 639 <span type="species:ncbi:10090">mice</span>
Previous studies have shown that immune control of F-MLV infection depends on all three of the major lymphocyte populations - CD4+ T cells, CD8+ T cells and B cells [24]. We wished to determine if T cell responses to F-MLV were defective in Myd88 knockout mice. We infected Myd88 heterozygous and homozygous mutant mice with F-MLV, and at 13 dpi analyzed CD8 T cells by staining with the Db-GagL tetramer (Figure 7A). In heterozygous mice, approximately 5-8% of the CD8+ T cell population stained positive with this tetramer (Figure 7A, left panel). In naive mice, CD8 cells were not significantly stained (0.2%). In homozygous mutant mice, the proportion of CD8+ T cells that was Db-GagL+ was significantly reduced to approximately 2% (Figure 7A, right panel). This indicates that the CD8+ T cell response to F-MLV is partially dependent on Myd88 signaling, but that Myd88-independent mechanisms can compensate in its absence.
###end p 40
###begin title 41
T cell responses to F-MLV are partially dependent on Myd88.
###end title 41
###begin p 42
###xml 149 150 142 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 194 195 184 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 199 200 189 190 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 221 222 211 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 280 281 267 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 285 286 272 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 506 507 483 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 511 512 488 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 15 19 <span type="species:ncbi:10090">mice</span>
###xml 392 396 <span type="species:ncbi:10090">mice</span>
###xml 599 603 <span type="species:ncbi:10090">mice</span>
Myd88 knockout mice and heterozygous littermates were infected with F-MLV for 14 days. (A) Splenocytes were stained with TCRbeta, CD8alpha, and the DbGagL tetramer, and the proportion of TCRbeta+ CD8+ cells that were GagL+ was measured. A representative FACS plot gated on TCRbeta+ CD8+ cells is shown in the upper panel. For the bar graph in the lower panel, each bar is the average of four mice. (B) Splenocytes were stained for TCRbeta, CD4, and intracellular interferon-gamma. The proportion of TCRbeta+ CD4+ T cells that expressed interferon-gamma was measured. Each bar is the average of four mice. The data shown are representative of three independent experiments.
###end p 42
###begin p 43
###xml 23 24 23 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 96 97 96 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 295 296 291 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 336 345 328 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000298-g007">Figure 7B</xref>
###xml 393 394 385 386 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 616 617 600 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 625 626 609 610 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
###xml 268 272 <span type="species:ncbi:10090">mice</span>
###xml 373 377 <span type="species:ncbi:10090">mice</span>
###xml 552 556 <span type="species:ncbi:10090">mice</span>
To determine if the CD4+ T cell response to F-MLV was affected by loss of Myd88, we analyzed CD4+ T cells in infected Myd88 heterozygous or homozygous mutant mice by intracellular staining for interferon-gamma (IFNgamma) expression. In naive heterozygous and knockout mice, roughly 3% of the CD4+ T cells stained positive for IFNgamma (Figure 7B). In infected heterozygous mice, 11% of the CD4+ T cells were IFNgamma positive, indicative of a robust Th1 response to F-MLV. By contrast, the proportion of IFNgamma positive CD4 T cells in Myd88 knockout mice was reduced to 6%. These results indicate that both the CD8+ and CD4+ T cell responses to F-MLV are present but reduced in the absence of Myd88.
###end p 43
###begin title 44
Myd88 is required for the generation of neutralizing antibodies to F-MLV
###end title 44
###begin p 45
###xml 328 349 328 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000298-g008">Figure 8, upper panel</xref>
###xml 523 544 523 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000298-g008">Figure 8, lower panel</xref>
###xml 183 187 <span type="species:ncbi:10090">mice</span>
###xml 221 225 <span type="species:ncbi:10090">mice</span>
###xml 397 401 <span type="species:ncbi:10090">mice</span>
###xml 609 613 <span type="species:ncbi:10090">mice</span>
###xml 916 920 <span type="species:ncbi:10090">mice</span>
To determine whether the B cell/antibody response to F-MLV was affected by loss of Myd88, we measured the titer of F-MLV-neutralizing antibodies in the serum of infected Myd88 mutant mice. At 14 dpi, heterozygous control mice exhibited a strong neutralizing antibody response to F-MLV with a titer typically in the range of 80 (Figure 8, upper panel). By contrast, in the serum of Myd88-deficient mice, neutralizing antibodies were undetectable. We also measured neutralizing antibody titers at eight weeks post-infection (Figure 8, lower panel), and found strong antibody titers in the serum of heterozygous mice but undetectable F-MLV-neutralizing activity in the homozygous mutant animals. Since it is known that B cells and neutralizing antibodies are required to control F-MLV, the results suggest that the lack of a neutralizing antibody response is a significant contributor to the failure of Myd88-deficient mice to control F-MLV.
###end p 45
###begin title 46
Myd88 is required for a neutralizing antibody response against F-MLV.
###end title 46
###begin p 47
###xml 63 68 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 68 71 68 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 81 84 81 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 223 228 <span type="species:ncbi:10090">mouse</span>
Serum was isolated from the peripheral blood of F-MLV-infected Myd88-/- and Myd88+/- littermate controls at 2 wpi and 8 wpi. The titer of neutralizing antibodies in the serum was measured. Each dot represents an individual mouse. The data shown are from one of four independent experiments.
###end p 47
###begin title 48
###xml 79 80 79 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
F-MLV-specific IgG is absent from serum of infected mice lacking Myd88 or CD11c+ DCs
###end title 48
###begin p 49
###xml 83 84 83 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 671 679 671 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000298-g009">Figure 9</xref>
###xml 997 998 997 998 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
###xml 329 333 <span type="species:ncbi:10090">mice</span>
###xml 427 431 <span type="species:ncbi:10090">mice</span>
###xml 507 512 <span type="species:ncbi:10090">mouse</span>
###xml 624 628 <span type="species:ncbi:10090">mice</span>
###xml 665 669 <span type="species:ncbi:10090">mice</span>
###xml 731 735 <span type="species:ncbi:10090">mice</span>
###xml 954 958 <span type="species:ncbi:10090">mice</span>
The absence of a detectable neutralizing antibody titer in Myd88-deficient or CD11c+ DC-deleted mice could reflect a general loss of serum antibodies to F-MLV or a defect specifically in antibodies that neutralize infection. To distinguish between these possibilities, we measured F-MLV-specific IgG levels in the serum of these mice at 14 dpi. F-MLV-specific antibodies were detected by incubating serum samples from infected mice with a suspension of an F-MLV-infected cell line, followed by staining for mouse IgG and flow cytometry. Staining activity was present in the serum of infected wild-type or Myd88 heterozygous mice, but absent from the serum of naive mice (Figure 9). Also, serum from wild-type or Myd88 heterozygous mice did not stain an uninfected cell line, indicating that the staining was specific for F-MLV (not shown). Significantly, F-MLV-specific IgG was completely absent from the serum of infected Myd88-deficient or DC-depleted mice. These data argue that Myd88 and CD11c+ DCs regulate the generation of total anti F-MLV IgG levels, and not only the amount of antibodies that neutralize viral infection.
###end p 49
###begin title 50
###xml 79 80 79 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
F-MLV-specific IgG is absent from serum of infected mice lacking Myd88 or CD11c+ DCs.
###end title 50
###begin p 51
###xml 317 318 317 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 187 192 <span type="species:ncbi:10090">mouse</span>
###xml 290 294 <span type="species:ncbi:10090">mice</span>
###xml 331 335 <span type="species:ncbi:10090">mice</span>
###xml 421 425 <span type="species:ncbi:10090">mice</span>
Serum samples from naive or infected mice were assayed for the presence of F-MLV-specific IgG, by incubation with a suspension of F-MLV-infected cells, followed by secondary staining for mouse IgG. The cells were then analyzed by flow cytometry. Representative stainings for Myd88 knockout mice (upper left) and CD11c+ DC-depleted mice (upper right) are shown. Mean fluorescence intensities (MFI) for the average of five mice were calculated for each condition and plotted (lower panel). The data shown are from one of two independent experiments.
###end p 51
###begin p 52
###xml 18 19 18 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 493 494 493 494 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 250 254 <span type="species:ncbi:10090">mice</span>
###xml 409 413 <span type="species:ncbi:10090">mice</span>
###xml 591 595 <span type="species:ncbi:10090">mice</span>
Since B cells, CD4+ T cells, and DCs are all known to regulate antibody responses, it is possible that an increased level of viral infection of one of these cell types during the acute phase was responsible for the antibody defect in Myd88-deficient mice. To examine this possibility, we examined the proportion of each of these cells that was infected with F-MLV at 6 dpi by staining splenocytes of infected mice for cell surface expression of the viral GlycoGag protein. Neither B cells, CD4+ T cells, nor DCs exhibited significantly higher proportions of infected cells in Myd88 knockout mice at this timepoint (not shown).
###end p 52
###begin title 53
###xml 30 34 <span type="species:ncbi:10090">mice</span>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
Serum from wild-type infected mice can rescue control of F-MLV in Myd88-deficient mice
###end title 53
###begin p 54
###xml 735 744 735 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000298-g010">Figure 10</xref>
###xml 1007 1008 1007 1008 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 104 108 <span type="species:ncbi:10090">mice</span>
###xml 224 228 <span type="species:ncbi:10090">mice</span>
###xml 273 277 <span type="species:ncbi:10090">mice</span>
###xml 331 335 <span type="species:ncbi:10090">mice</span>
###xml 372 376 <span type="species:ncbi:10090">mice</span>
###xml 462 466 <span type="species:ncbi:10090">mice</span>
###xml 475 479 <span type="species:ncbi:10090">mice</span>
###xml 597 601 <span type="species:ncbi:10090">mice</span>
###xml 672 676 <span type="species:ncbi:10090">mice</span>
###xml 756 760 <span type="species:ncbi:10090">mice</span>
###xml 838 842 <span type="species:ncbi:10090">mice</span>
###xml 869 873 <span type="species:ncbi:10090">mice</span>
###xml 928 932 <span type="species:ncbi:10090">mice</span>
###xml 1076 1080 <span type="species:ncbi:10090">mice</span>
###xml 1128 1132 <span type="species:ncbi:10090">mice</span>
Because the most profound defect associated with the poor control of F-MLV infection in Myd88-deficient mice was the lack of a neutralizing antibody response, we asked whether passive transfer of immune serum from wild-type mice could rescue control of F-MLV in the mutant mice. We infected Myd88 heterozygous or homozygous mutant mice with F-MLV, and at 7 dpi homozygous mice were injected intraperitoneally with 0.5 ml of serum taken either from naive C57BL/6 mice or from mice that had been infected with F-MLV 14 days earlier. Consistent with our previous observations, at 14 dpi heterozygous mice had low numbers of viral foci in their spleens, while Myd88-deficient mice exhibited approximately 1000-fold higher numbers of foci (Figure 10). Knockout mice that had received naive serum had virus titers similar to untreated knockout mice. However, Myd88-deficient mice that had received serum from wild-type F-MLV-infected mice had virus levels that were more than 100-fold lower, with approximately 103 foci per spleen. This indicates that serum from wild-type infected mice can rescue control of F-MLV in Myd88-deficient mice, and is consistent with the finding that the most important role of Myd88 in F-MLV infection is the generation of a virus-specific neutralizing antibody response.
###end p 54
###begin title 55
###xml 42 46 <span type="species:ncbi:10090">mice</span>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
Transfer of serum from infected wild-type mice to Myd88 knockout mice rescues control of F-MLV.
###end title 55
###begin p 56
###xml 15 19 <span type="species:ncbi:10090">mice</span>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
###xml 172 176 <span type="species:ncbi:10090">mice</span>
###xml 193 197 <span type="species:ncbi:10090">mice</span>
###xml 323 327 <span type="species:ncbi:10090">mice</span>
###xml 382 386 <span type="species:ncbi:10090">mice</span>
Myd88 knockout mice or heterozygous littermates were infected with F-MLV. At 7 dpi, infected mice were injected intraperitoneally with 0.5 ml serum from uninfected C57BL/6 mice or from C57BL/6 mice that had been infected with F-MLV for 14 days. At 14 dpi, the levels of viral focus-forming units in the spleens of infected mice were analyzed. Each bar represents the average of 4-7 mice from one of two independent experiments.
###end p 56
###begin title 57
Discussion
###end title 57
###begin p 58
###xml 275 276 275 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 440 441 440 441 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 449 450 449 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 781 784 781 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 983 987 983 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Jung1">[23]</xref>
###xml 988 992 988 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Probst1">[25]</xref>
###xml 1193 1194 1193 1194 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 509 513 <span type="species:ncbi:10090">mice</span>
Although innate immune detection of viral pathogens is considered to be important for the initiation of adaptive immune responses, for most viruses, including retroviruses, the specific sensing pathway has not been identified. Our results demonstrate a crucial role for CD11c+ DCs and Toll-like receptor signaling in the antibody response to retroviral infection. We have also identified a significant but less critical role for TLRs in CD4+ and CD8+ T cell responses to retroviral infection. Myd88-deficient mice sustain high titers of F-MLV for several months post-infection, indicating that the response is not simply delayed. To our knowledge, this is the first report of Myd88 or TLR signaling playing an essential role in immune control of a virus that is primarily mediated via the anti-viral antibody response. Similarly, previous studies of the effect of DC depletion in immune control of pathogens have focused on T cell responses, rather than on antibody-mediated control [23],[25]. Our results demonstrate that depletion of DCs leads to a loss of immune control of F-MLV, and this was found to coincide with a complete loss of F-MLV-specific IgG but no significant reduction in CD8+ T cells responses.
###end p 58
###begin p 59
###xml 246 250 246 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Pasare1">[26]</xref>
###xml 596 600 594 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Gavin1">[27]</xref>
###xml 621 624 619 622 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 629 638 627 636 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LPS2/LPS2</sup>
###xml 616 638 614 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88<sup>&#8722;/&#8722;</sup>;Trif<sup>LPS2/LPS2</sup></italic>
###xml 134 138 <span type="species:ncbi:10090">mice</span>
###xml 334 338 <span type="species:ncbi:10090">mice</span>
###xml 407 411 <span type="species:ncbi:10090">mice</span>
###xml 462 466 <span type="species:ncbi:10090">mice</span>
###xml 639 643 <span type="species:ncbi:10090">mice</span>
The role of TLRs in B cell dependent immune responses has been somewhat controversial. Pasare and Medzhitov found that Myd88 knockout mice were defective at generating antibodies specific for the model antigens OVA and HSA in the presence of LPS [26]. Furthermore, they found this defect to be at least partly B cell intrinsic, since mice lacking mature B cells due to a disruption of the Ig mu chain (muMT mice) that had received B cells lacking Myd88, but not mice that had received wild-type B cells, also had defective antibody responses. This view has been challenged by Gavin and coworkers [27] who found that Myd88-/-;TrifLPS2/LPS2 mice were able to mount apparently normal antibody responses to the model antigen trinitrophenol-hemocyanin given in complete Freund's adjuvant. However, neither of these studies examined the requirement of TLR signaling for an antibody response in the context of a live viral infection, nor did they examine the ability of the antibody response to neutralize an infectious pathogen. The issue of whether or not TLR signaling is important for effective neutralizing antibody responses is of profound importance for vaccine design, and the work that we describe here strongly suggests that, for retroviral pathogens, functional TLR signaling is indeed required for the antibody response.
###end p 59
###begin p 60
###xml 243 247 243 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Heer1">[28]</xref>
###xml 435 442 435 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 442 446 442 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Guay1">[29]</xref>
###xml 691 695 691 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Zhou1">[30]</xref>
###xml 696 700 696 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Lang1">[31]</xref>
###xml 167 171 <span type="species:ncbi:10090">mice</span>
###xml 379 383 <span type="species:ncbi:10090">mice</span>
###xml 479 483 <span type="species:ncbi:10090">mice</span>
###xml 628 632 <span type="species:ncbi:10090">mice</span>
Some previous reports have indicated a role for TLRs in the development of antibody responses during viral infection. Heer and coworkers found that, in Myd88 knockout mice, antibodies specific for influenza exhibited defective class switching [28]. Furthermore, it has been shown that long term maintenance of antibodies to polyoma virus required Myd88, although Myd88-deficient mice were still able to control polyoma virus infection in vivo[29]. Interestingly, Myd88-deficient mice that were infected with Vesicular Stomatitis Virus exhibited higher levels of VSV-specific IgG1 but lower levels of IgG2a relative to wild type mice, while the neutralizing antibody titer was somewhat lower [30],[31].
###end p 60
###begin p 61
###xml 174 175 174 175 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 215 219 215 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Jung2">[32]</xref>
###xml 220 224 220 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Zhou2">[33]</xref>
###xml 245 246 245 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 276 280 276 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Heer1">[28]</xref>
###xml 210 214 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
Previous studies of the roles played by TLRs in anti-viral immune responses have shown significant differences from virus to virus. For example, Myd88 is required for the CD8+ T cell response to the arenavirus LCMV [32],[33], but not for the CD8+ T cell response to influenza [28]. The reason for the differential requirement for TLRs in the immune response to different viruses is not clear but could be related to the structural features of the virus, cell tropism, or the details of the replication strategy used by the virus.
###end p 61
###begin p 62
###xml 241 242 241 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 250 251 250 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 273 274 273 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 430 431 430 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 547 548 543 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 635 636 631 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 889 893 881 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Bergtold1">[34]</xref>
###xml 1038 1042 1030 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Jegerlehner1">[35]</xref>
###xml 707 711 <span type="species:ncbi:10090">mice</span>
The specific cell type(s) in which TLR signaling is required for the antibody response to F-MLV is not clear. TLR signaling in DCs promotes the expression of costimulatory molecules such as CD80 and CD86 that are important for triggering CD4+ and CD8+ T cell responses. CD4+ T cells, in turn, play an important role in activating B cells. Thus, the effect of DCs and TLR signaling on B cell responses could be mediated through CD4+ T cells. However, upregulation of CD80 on the DC population (CD11c+, B220-, CD8alpha-) that is known to control CD4+ T cell responses was only slightly reduced in the absence of Myd88. Similarly, the CD4+ T cell response to F-MLV was reduced but not absent in Myd88 knockout mice. DCs are known to activate B cells directly in a T cell independent manner by FcgammaRIIB-mediated recycling of whole antigen, but this process is not known to be TLR dependent [34]. It is possible that DCs release cytokines in a Myd88-dependent manner that directly affects B cell responses. Also, since B cells express TLRs [35], it is possible that TLR signaling is directly required in B cells to generate F-MLV-specific antibodies. Conditional deletion of Myd88 in DCs or B cells would address the relative contribution of Myd88-dependent signaling in these cell types.
###end p 62
###begin p 63
###xml 460 464 460 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Takaoka1">[36]</xref>
###xml 621 625 621 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Shi1">[37]</xref>
These results also suggest that DC-independent and Myd88-independent pathways contribute to the development of the T cell responses. Since retroviral genomes fold into structures that contain dsRNA, it is possible that TLR3 and TRIF could be involved. Also, since the retroviral replication cycle involves the generation of dsDNA in the cytoplasm of infected cells, it its possible that a cytoplasmic DNA sensor such as DAI contributes to retroviral detection [36]. Cellular molecules that are released from damaged cells, such as uric acid and ATP, have also been shown to have the ability to stimulate immune responses [37], but most retroviruses, including F-MLV, are non-cytopathic and do not cause the death of infected cells.
###end p 63
###begin p 64
###xml 56 57 56 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 359 360 358 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 472 476 471 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Messer1">[38]</xref>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 325 329 <span type="species:ncbi:10090">mice</span>
Since DC-depleted mice can still mount a significant CD8+ T cell response to F-MLV, it is possible that another antigen presenting cell type is sufficient to mediate this function. Depletion of other antigen presenting cells such as B cells and macrophages could be used to address this issue, although B cell-deficient muMT mice are still able to mount a CD8+ T cell response to F-MLV, indicating that an essential role for B cells in the CD8 T cell response is unlikely [38].
###end p 64
###begin p 65
###xml 572 576 572 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Tritel1">[39]</xref>
###xml 708 712 708 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-WilleReece1">[40]</xref>
###xml 87 90 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 703 707 <span type="species:ncbi:10090">mice</span>
###xml 816 819 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Could manipulation of TLR signaling potentially be used to enhance effectiveness of an HIV vaccine? It has been argued that effective vaccines, such as live attenuated vaccines, are able to provide effective protection because they stimulate TLRs. Furthermore, most effective vaccines involve the use of adjuvants that contain TLR ligands, although for many of these the role of TLR signaling has not been conclusively demonstrated. One study found that administration of the TLR9 ligand CpG enhanced the cellular and humoral response induced by a Gag prime boost vaccine [39]. Also, it has been demonstrated that conjugating Gag to the TLR7 agonist R-848 enhanced Gag-specific Th1 and CD8 responses in mice [40]. It remains to be determined, however, whether either of these approaches will enhance protection from HIV infection.
###end p 65
###begin p 66
###xml 369 373 369 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Messer1">[38]</xref>
###xml 102 105 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
B cell vaccines and T cell vaccines have by themselves been unsuccessful in eliciting protection from HIV infection. For F-MLV, Messer and coworkers found that neither vaccination with the cell line FBL3 that expresses the viral protein GlycoGag to stimulate T cell responses nor passive transfer of neutralizing antibodies is sufficient to elicit sterilizing immunity [38]. However, the combination of immune serum and the FBL3 T cell vaccine did result in sterilizing immunity.
###end p 66
###begin p 67
###xml 433 437 433 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Burton1">[41]</xref>
###xml 17 20 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 30 38 <span type="species:ncbi:9606">patients</span>
###xml 176 179 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 341 344 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 354 361 <span type="species:ncbi:9606">persons</span>
The issue of why HIV infected patients fail to develop an effective neutralizing antibody response remains unresolved. If TLR signaling is involved in the antibody response to HIV, it is conceivable that viral disruption of TLR signaling could contribute to the failure of this response. However, virus specific antibodies are not absent in HIV infected persons, but they lack sufficient neutralizing activity to control the viremia [41]. Our findings indicate that Myd88 plays a fundamental role in the generation of a total retroviral antibody response rather than specifically neutralizing antibodies.
###end p 67
###begin p 68
###xml 158 165 158 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 421 424 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
In summary, these results demonstrate a critical role for DCs and TLR signaling in the humoral immune response to retroviral infection, and provide the first in vivo examination of the role played by TLRs in immune control of retroviral pathogens. Understanding precisely how TLR signaling contributes to the anti-retroviral immune response will help to guide the development of vaccines for retroviral pathogens such as HIV.
###end p 68
###begin title 69
Materials and Methods
###end title 69
###begin title 70
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 70
###begin p 71
###xml 369 373 369 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000298-Jung1">[23]</xref>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 194 198 <span type="species:ncbi:10090">mice</span>
###xml 333 337 <span type="species:ncbi:10090">mice</span>
###xml 442 447 <span type="species:ncbi:10090">mouse</span>
Wild-type C57BL/6 mice were obtained from Taconic Farms. Myd88-deficient mice were a gift from R. Medzhitov and were backcrossed to the C57BL/6 background for 5 generations. The Myd88-deficient mice were originally developed in the laboratory of S. Akira (Osaka, Japan). For all experiments, littermate controls were used. CD11c-DTR mice have been previously described [23], and had been generated on C57BL/6 background. Ethical approval for mouse experiments was obtained from the NYU Medical Center Institutional Animal Care and Use Committee.
###end p 71
###begin title 72
Viral infections
###end title 72
###begin p 73
###xml 51 55 <span type="species:ncbi:10090">mice</span>
###xml 204 208 <span type="species:ncbi:10090">mice</span>
F-MLV stocks were generated by infection of Balb/c mice with 5000 focus-forming units of F-MLV. At 14 dpi, a 10% spleen homogenate suspension was made and titered by focus-forming assay. For experiments, mice at 6-8 weeks of age were infected with 7000 focus-forming units of F-MLV by retro-orbital intravenous injection.
###end p 73
###begin title 74
Focus-forming assays
###end title 74
###begin p 75
###xml 112 121 112 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mus Dunni</italic>
###xml 151 152 151 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 157 158 157 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 189 190 189 190 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 190 199 190 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mus Dunni</italic>
###xml 500 505 <span type="species:ncbi:10090">mouse</span>
###xml 511 522 <span type="species:ncbi:3704">horseradish</span>
Splenocytes in suspension were serially diluted and plated on a subconfluent monolayer of the F-MLV-susceptible Mus Dunni cell line. For platings, 5x101-5x106 splenocytes were added to 2x105Mus Dunni cells in 6 well plates. After 3 days of co-culture in RPMI medium, the cells were fixed with methanol and stained for 2 hours with the monoclonal antibody mAb720, which recognizes the F-MLV envelope glycoprotein. The cells were washed three times with phosphate-buffered saline and stained with anti-mouse IgG1 horseradish peroxidase for one hour. Foci were then visualized by adding Amino ethyl Carbazole/Hydrogen peroxide substrate (Sigma).
###end p 75
###begin title 76
###xml 30 31 30 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Bone marrow chimeras and CD11c+ DC depletions
###end title 76
###begin p 77
###xml 426 427 426 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 201 216 <span type="species:ncbi:10090">transgenic mice</span>
###xml 326 330 <span type="species:ncbi:10090">mice</span>
Wild-type C57BL/6 mice at 6-8 weeks of age were lethally irradiated with two doses of 550 Rads separated by six hours and then injected intravenously with bone marrow cells from wild-type or CDllc-DTR transgenic mice. The chimeras were then kept for 6 weeks to permit engraftment of donor bone marrow. During this period, the mice were supplied with antibiotics in their drinking water to prevent infection. Depletion of CD11c+ dendritic cells was carried out by fifteen days of daily intraperitoneal injection of 200 ng of diphtheria toxin (Sigma).
###end p 77
###begin title 78
Intracellular cytokine staining
###end title 78
###begin p 79
Splenocytes were plated in RPMI containing 50 ng/mL PMA and 1 uM ionomycin plus GolgiStop (BD Biosciences). After 3 h stimulation, cells were washed in PBS and stained for cell surface markers. The cells were then washed in PBS and resuspended in permeabilization-fixing buffer (BD Biosciences). After incubation at 4degreesC for 45 minutes, the cells were washed and resuspended in permeabilization/wash buffer containing anti-IFNgamma-PE antibody. Staining was carried out at for 45-60 min at 4degreesC. Finally, the cells were washed in 1-2 mL BD perm/wash buffer and resuspended in PBS for analysis.
###end p 79
###begin title 80
Neutralizing antibody titers
###end title 80
###begin p 81
###xml 253 262 253 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mus Dunni</italic>
###xml 297 306 297 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mus Dunni</italic>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
To measure neutralizing antibody titers in infected mice, peripheral blood was obtained by retro-orbital bleed, and serum extracted by centrifugation. The serum was diluted in a two-fold dilution series, and mixed with an F-MLV sample before plating on Mus Dunni cells. Three days later, when the Mus Dunni cells were confluent, infected foci were visualized. The neutralizing antibody titer was defined as the maximum serum dilution that reduced the number of F-MLV foci by at least 75%.
###end p 81
###begin title 82
F-MLV-specific IgG assay
###end title 82
###begin p 83
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 96 102 <span type="species:ncbi:9913">bovine</span>
###xml 204 208 <span type="species:ncbi:11819?1.0">SFFV</span>
###xml 428 433 <span type="species:ncbi:10090">mouse</span>
Serum samples from infected or naive mice were diluted in phosphate buffer saline with 2% fetal bovine serum. Samples were then incubated with a suspension of the chronically F-MLV-infected cell line NRK/SFFV-57 on ice for 45 minutes to capture F-MLV-specific antibodies. 100,000 cells were used per staining. The cells were then washed twice and resuspended in PBS/FBS. Secondary staining using Allophycocyanin-conjugated anti-mouse IgG (eBiosciences) was performed, then the cells were analyzed by flow cytometry.
###end p 83
###begin title 84
Statistical analysis
###end title 84
###begin p 85
###xml 121 131 121 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000298-g003">Figures 3B</xref>
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000298-g004">4A</xref>
###xml 141 142 141 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000298-g007">7</xref>
###xml 173 183 173 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000298-g003">Figures 3A</xref>
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000298-g004">4B</xref>
###xml 189 190 189 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000298-g008">8</xref>
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000298-g010">10</xref>
To determine statistical significance, P values for specific experiments were calculated using the Student's T- test for Figures 3B, 4A, and 7, and by Mann-Whitney test for Figures 3A, 4B, 8, and 10.
###end p 85
###begin p 86
We are grateful to Dr. Kim Hasenkrug and Dr. Leonard Evans for generous gifts of reagents.
###end p 86
###begin title 87
References
###end title 87
###begin article-title 88
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites.
###end article-title 88
###begin article-title 89
###xml 4 9 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens.
###end article-title 89
###begin article-title 90
###xml 19 22 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression.
###end article-title 90
###begin article-title 91
###xml 35 38 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction.
###end article-title 91
###begin article-title 92
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 T-cell vaccines: evaluating the next step.
###end article-title 92
###begin article-title 93
The Toll receptor family and microbial recognition.
###end article-title 93
###begin article-title 94
Recognition of microbial infection by Toll-like receptors.
###end article-title 94
###begin article-title 95
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8.
###end article-title 95
###begin article-title 96
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA.
###end article-title 96
###begin article-title 97
Double-stranded RNA signaling by Toll-like receptor 3 requires specific tyrosine residues in its cytoplasmic domain.
###end article-title 97
###begin article-title 98
A Toll-like receptor recognizes bacterial DNA.
###end article-title 98
###begin article-title 99
MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways.
###end article-title 99
###begin article-title 100
Toll-like receptor signaling pathways.
###end article-title 100
###begin article-title 101
Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.
###end article-title 101
###begin article-title 102
Immunity to retroviral infection: the Friend virus model.
###end article-title 102
###begin article-title 103
Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection.
###end article-title 103
###begin article-title 104
###xml 46 81 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligands.
###end article-title 104
###begin article-title 105
###xml 15 20 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions.
###end article-title 105
###begin article-title 106
###xml 81 118 <span type="species:ncbi:11048">lactate dehydrogenase-elevating virus</span>
Suppression of acute anti-friend virus CD8+ T-cell responses by coinfection with lactate dehydrogenase-elevating virus.
###end article-title 106
###begin article-title 107
###xml 65 70 <span type="species:ncbi:9606">human</span>
The nature of the principal type 1 interferon-producing cells in human blood.
###end article-title 107
###begin article-title 108
Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation.
###end article-title 108
###begin article-title 109
Host genetic factors that control immune responses to retrovirus infections.
###end article-title 109
###begin article-title 110
In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens.
###end article-title 110
###begin article-title 111
The role of CD4 and CD8 T cells in recovery and protection from retroviral infection: lessons from the Friend virus model.
###end article-title 111
###begin article-title 112
###xml 19 53 <span type="species:ncbi:11623">lymphocytic choriomeningitis virus</span>
Priming of CTLs by lymphocytic choriomeningitis virus depends on dendritic cells.
###end article-title 112
###begin article-title 113
Control of B-cell responses by Toll-like receptors.
###end article-title 113
###begin article-title 114
Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling.
###end article-title 114
###begin article-title 115
TLR signaling fine-tunes anti-influenza B cell responses without regulating effector T cell responses.
###end article-title 115
###begin article-title 116
MyD88 is required for the formation of long-term humoral immunity to virus infection.
###end article-title 116
###begin article-title 117
###xml 51 77 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
Role of MyD88 in route-dependent susceptibility to vesicular stomatitis virus infection.
###end article-title 117
###begin article-title 118
###xml 62 88 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
MyD88 protects from lethal encephalitis during infection with vesicular stomatitis virus.
###end article-title 118
###begin article-title 119
Lymphocytoid choriomeningitis virus activates plasmacytoid dendritic cells and induces a cytotoxic T-cell response via MyD88.
###end article-title 119
###begin article-title 120
###xml 83 117 <span type="species:ncbi:11623">lymphocytic choriomeningitis virus</span>
MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection.
###end article-title 120
###begin article-title 121
Cell surface recycling of internalized antigen permits dendritic cell priming of B cells.
###end article-title 121
###begin article-title 122
TLR9 signaling in B cells determines class switch recombination to IgG2a.
###end article-title 122
###begin article-title 123
DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response.
###end article-title 123
###begin article-title 124
Molecular identification of a danger signal that alerts the immune system to dying cells.
###end article-title 124
###begin article-title 125
Essential role for virus-neutralizing antibodies in sterilizing immunity against Friend retrovirus infection.
###end article-title 125
###begin article-title 126
###xml 29 34 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Prime-boost vaccination with HIV-1 Gag protein and cytosine phosphate guanosine oligodeoxynucleotide, followed by adenovirus, induces sustained and robust humoral and cellular immune responses.
###end article-title 126
###begin article-title 127
###xml 18 23 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 96 101 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Immunization with HIV-1 Gag protein conjugated to a TLR7/8 agonist results in the generation of HIV-1 Gag-specific Th1 and CD8+ T cell responses.
###end article-title 127
###begin article-title 128
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HIV vaccine design and the neutralizing antibody problem.
###end article-title 128
###begin p 129
The authors have declared that no competing interests exist.
###end p 129
###begin p 130
This work was supported by the Howard Hughes Medical Institute (DRL), and by grants R37 AI033303-16 and R01 AI033856-14. EPB was supported by a Damon Runyon Cancer Research Foundation postdoctoral fellowship. The authors have no financial interest in this manuscript or the work described in it.
###end p 130

